U.S. markets closed

Can-Fite BioPharma Ltd. (CANF)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
2.0600+0.0900 (+4.57%)
At close: 3:59PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/14/2021
Current
12/31/20209/30/2020
Market Cap (intraday) 5
36.55M28.70M27.49M
Enterprise Value 3
28.27M18.47M18.41M
Trailing P/E
N/AN/AN/A
Forward P/E 1
N/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/A
Price/Sales (ttm)
30.8520.0913.90
Price/Book (mrq)
5.582.882.98
Enterprise Value/Revenue 3
37.05123.1487.26
Enterprise Value/EBITDA 7
-2.01-5.29-7.43

Trading Information

Stock Price History

Beta (5Y Monthly) 1.55
52-Week Change 34.00%
S&P500 52-Week Change 341.30%
52 Week High 34.3900
52 Week Low 31.5100
50-Day Moving Average 32.2138
200-Day Moving Average 32.0645

Share Statistics

Avg Vol (3 month) 33.65M
Avg Vol (10 day) 3203.34k
Shares Outstanding 517.19M
Implied Shares Outstanding 6N/A
Float 16.53M
% Held by Insiders 11.07%
% Held by Institutions 110.74%
Shares Short (Apr 29, 2021) 4542.43k
Short Ratio (Apr 29, 2021) 41.91
Short % of Float (Apr 29, 2021) 4N/A
Short % of Shares Outstanding (Apr 29, 2021) 43.16%
Shares Short (prior month Mar 30, 2021) 4895.24k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 09, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3May 09, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,853.08%

Management Effectiveness

Return on Assets (ttm)-99.87%
Return on Equity (ttm)-339.20%

Income Statement

Revenue (ttm)763k
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)-21.90%
Gross Profit (ttm)763k
EBITDA -14.13M
Net Income Avi to Common (ttm)-14.44M
Diluted EPS (ttm)-1.2000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.34M
Total Cash Per Share (mrq)0.49
Total Debt (mrq)67k
Total Debt/Equity (mrq)1.10
Current Ratio (mrq)7.41
Book Value Per Share (mrq)0.39

Cash Flow Statement

Operating Cash Flow (ttm)-12.06M
Levered Free Cash Flow (ttm)-7.41M